Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo.

Golovine K, Makhov P, Uzzo RG, Shaw T, Kunkle D, Kolenko VM.

Clin Cancer Res. 2008 Sep 1;14(17):5376-84. doi: 10.1158/1078-0432.CCR-08-0455.

2.

hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.

Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC.

Mol Cancer. 2005 Sep 9;4:32.

3.

Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.

Golovine K, Uzzo RG, Makhov P, Crispen PL, Kunkle D, Kolenko VM.

Prostate. 2008 Sep 15;68(13):1443-9. doi: 10.1002/pros.20810.

4.

hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).

Zou J, Milon BC, Desouki MM, Costello LC, Franklin RB.

Prostate. 2011 Oct 1;71(14):1518-24. doi: 10.1002/pros.21368. Epub 2011 Feb 25.

6.

Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.

Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM.

Carcinogenesis. 2006 Oct;27(10):1980-90. Epub 2006 Apr 10.

7.
9.

Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells.

Milon BC, Agyapong A, Bautista R, Costello LC, Franklin RB.

Prostate. 2010 Feb 15;70(3):288-96. doi: 10.1002/pros.21063.

10.

Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells.

Makhov P, Golovine K, Uzzo RG, Wuestefeld T, Scoll BJ, Kolenko VM.

Gene. 2009 Feb 15;431(1-2):39-46. doi: 10.1016/j.gene.2008.10.015. Epub 2008 Nov 5.

11.
12.
13.

Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells.

Ginzburg S, Golovine KV, Makhov PB, Uzzo RG, Kutikov A, Kolenko VM.

Prostate. 2014 Feb;74(2):177-86. doi: 10.1002/pros.22739. Epub 2013 Oct 22.

14.
15.

Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.

Fang Y, Sun H, Zhai J, Zhang Y, Yi S, Hao G, Wang T.

Asian Pac J Cancer Prev. 2011;12(10):2721-6.

16.

Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents.

Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM.

Clin Cancer Res. 2002 Nov;8(11):3579-83.

17.

4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.

Lee NJ, Oh JH, Ban JO, Shim JH, Lee HP, Jung JK, Ahn BW, Yoon DY, Han SB, Ham YW, Hong JT.

Br J Pharmacol. 2013 Mar;168(5):1133-45. doi: 10.1111/j.1476-5381.2012.02235.x.

18.

Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo.

Syrovets T, Gschwend JE, Büchele B, Laumonnier Y, Zugmaier W, Genze F, Simmet T.

J Biol Chem. 2005 Feb 18;280(7):6170-80. Epub 2004 Dec 2.

19.

Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.

Andrzejewski T, Deeb D, Gao X, Danyluk A, Arbab AS, Dulchavsky SA, Gautam SC.

Oncol Res. 2008;17(6):257-67.

PMID:
19192720
20.

Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells.

Li Y, Chinni SR, Sarkar FH.

Front Biosci. 2005 Jan 1;10:236-43. Print 2005 Jan 1.

PMID:
15574364
Items per page

Supplemental Content

Write to the Help Desk